SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

SYNLOGIC, INC.
Date: Aug. 13, 2025 · CIK: 0001527599 · Accession: 0000000000-25-008506

Offering / Registration Process

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-289415

Date
August 13, 2025
Author
Division of
Form
UPLOAD
Company
SYNLOGIC, INC.

Letter

Re: Synlogic, Inc. Registration Statement on Form S-3 Filed August 8, 2025 File No. 333-289415 Dear Mary Beth Dooley:

August 13, 2025

Mary Beth Dooley Principal Executive Officer Synlogic, Inc. PO Box 30 Winchester, MA 01890

This is to advise you that we have not reviewed and will not review your registration statement.

Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Please contact Doris Stacey Gama at 202-551-3188 with any questions.

Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Nishant Dharia, Esq.

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 August 13, 2025

Mary Beth Dooley
Principal Executive Officer
Synlogic, Inc.
PO Box 30
Winchester, MA 01890

 Re: Synlogic, Inc.
 Registration Statement on Form S-3
 Filed August 8, 2025
 File No. 333-289415
Dear Mary Beth Dooley:

 This is to advise you that we have not reviewed and will not review your
registration
statement.

 Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you
that the company and its management are responsible for the accuracy and
adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.

 Please contact Doris Stacey Gama at 202-551-3188 with any questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Life
Sciences
cc: Nishant Dharia, Esq.
</TEXT>
</DOCUMENT>